Ovarian Cancer Talk

Thank you to all who participated in our Ovarian Cancer Talk interactive video chat on Monday, September 22, 2014.

Watch a recording or read a transcript of the entire broadcast.

 

Panel Members

 

Kunle Odunsi,
MD, PhD, FRCOG, FACOG

Adekunle "Kunle" Odunsi is Chair of the Department of Gynecologic Oncology, Executive Director of the Center for Immunotherapy and Co-Leader of the Tumor Immunology and Immunotherapy research program at RPCI. Dr. Odunsi is the principal investigator for the Ovarian Cancer SPORE grant.

Yeong “Christopher” Choi,
PhD

Yeong "Christopher" Choi is an Assistant Professor of Oncology and Director of the Center for Immunotherapy Good Manufacturing Practice (GMP) Therapeutic Cell Production Facility at RPCI. He has spent a decade in the development of cell and gene-based therapies to improve the medical outcome of life-threatening diseases.

 

Mollie Hutton,
MS, CGC

Mollie Hutton is a Certified Genetic Counselor in the Clinical Genetics Service Department at Roswell Park. She identifies genetic factors associated with hereditary cancer syndromes and calculates increased familial risk.

Hear from Mollie

Kirsten Moysich,
PhD, MS

Kirsten Moysich is a Professor of Oncology in the Department of Cancer Prevention and Control and Department of Immunology. She is the Co-Principal Investigator of the Ovarian Cancer SPORE project, and is the Co-Leader of the RPCI Gynecological Cancer Disease Site Research Group, which focuses on translational ovarian cancer research.

 

When it Comes to Cancer, Having Options is Important

Whether you are newly diagnosed, are in remission, or have relapsed, we have ovarian cancer treatment options for you.

Learn More